Abeona Therapeutics (ABEO) Accumulated Expenses (2010 - 2026)

Abeona Therapeutics' Accumulated Expenses history runs 15 years deep, the most recent figure standing at $5.4 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 190.48% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (up 190.48% YoY), while the FY2025 annual figure was $5.6 million, down 11.01% from the prior year.
• Accumulated Expenses was $5.4 million for Q1 2026 at Abeona Therapeutics, down from $5.6 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $6.3 million in Q4 2024 to a low of $745000.0 in Q1 2022.
• Historically, Accumulated Expenses has averaged $3.7 million across 5 years, with a median of $3.7 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses plunged 74.02% in 2022, then soared 244.83% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $2.6 million in 2022, then surged by 130.81% to $6.0 million in 2023, then rose by 5.81% to $6.3 million in 2024, then dropped by 11.01% to $5.6 million in 2025, then decreased by 4.76% to $5.4 million in 2026.
• The last three Accumulated Expenses figures came in at $5.4 million (Q1 2026), $5.6 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.